

Absci (NASDAQ:ABSI) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided...
You can purchase shares of Absci (NASDAQ:ABSI) through any online brokerage.
Other companies in Absci’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Absci has a consensus price target of $13.99.
The stock price for Absci (NASDAQ: ABSI) is $9.3579 last updated November 13, 2026 at 5:31 AM EST.
There are no upcoming dividends for Absci.
Absci does not have any upcoming earnings scheduled.
There is no upcoming split for Absci.
Absci is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line...